Related references
Note: Only part of the references are listed.CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice
Victor A. Drover et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice
Susanna M. Hofmann et al.
DIABETES (2008)
Pathophysiology of obesity: Why surgery remains the most effective treatment
Talat Waseem et al.
OBESITY SURGERY (2007)
Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane
Martin Knoepfel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles
Eric D. Labonte et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Fatty acid transport protein 4 is the principal very long chain fatty Acyl-CoA synthetase in skin fibroblasts
Zhenzhen Jia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine
Fatiha Nassir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Drug treatment of the overweight patient
George A. Bray et al.
GASTROENTEROLOGY (2007)
Deficiency of Niemann-Pick C1 like 1 prevents atherosclerosis in ApoE-/- mice
Harry R. Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
A model for fatty acid transport into the brain
James A. Hamilton et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
GLUT4 is internalized by a cholesterol-dependent nystatin-sensitive mechanism inhibited by insulin
Vincent Blot et al.
EMBO JOURNAL (2006)
Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4
Katrin Milger et al.
JOURNAL OF CELL SCIENCE (2006)
How fatty acids of different chain length enter and leave cells by free diffusion
Frits Kamp et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2006)
Plant stanol ascorbate esters reduce body weight gain through decreased energy absorption in hamsters
N Ebine et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake
LQ Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The target of ezetimibe is Niemann-Pick Cl-Like 1 (NPC1L1)
M Garcia-Calvo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein
SPN Iyer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption
JJ Repa et al.
JOURNAL OF LIPID RESEARCH (2005)
Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia
JP Davies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Enzymatic properties of purified murine fatty acid transport protein 4 and analysis of acyl-CoA synthetase activities in tissues from FATP4 null mice
AM Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Class B scavenger receptor-mediated intestinal absorption of dietary ß-carotene and cholesterol
A van Bennekum et al.
BIOCHEMISTRY (2005)
Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia
PP Toth et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Sphingomyelinase activates GLUT4 translocation via a cholesterol-dependent mechanism
P Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis
HR Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A novel, noninvasive method for the measurement of intestinal fat absorption
RJ Jandacek et al.
GASTROENTEROLOGY (2004)
Role of FATP in parenchymal cell fatty acid uptake
J Pohl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2004)
Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality
RE Gimeno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inhibition of intestinal cholesterol absorption by ezetimibe in humans
T Sudhop et al.
CIRCULATION (2002)
New insights into the fatty acid-binding protein (FABP) family in the small intestine
P Besnard et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Intestinal lipid absorption is not affected in CD36 deficient mice
JR Goudriaan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin
T Kosoglou et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects
JE Patrick et al.
DRUG METABOLISM AND DISPOSITION (2002)
The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption
SW Altmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice
HR Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Effects of a novel hydrophilic phytostanol analog on plasma lipid concentrations in gerbils
KM Wasan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function
M van Heek et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies
HE Bays et al.
CLINICAL THERAPEUTICS (2001)
Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters
M van Heek et al.
DIABETES (2001)
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe
F Ezzet et al.
CLINICAL THERAPEUTICS (2001)
The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys
M van Heek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Share Paper
